CasLoc logo
All Cases PTAB Litigations UPC Oppositions

GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA

1:14-cv-00877

Overview

Case Number 1:14-cv-00877
Filing Date 2014-07-03
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:1 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Glenmark Pharmaceuticals Inc., USA Operating Company

Represented By

7 Attorneys Listed

Kurt A. Mathas

Email: kurt.mathas@winstontaylor.com

George C. Lombardi

Email: glombard@winston.com

Emily N. Winfield

UNDELIVERABLE EMAIL 8/23/2019

Emily L. Hussey

UNDELIVERABLE EMAIL 3/22/2018

Alison S. Cooney

UNDELIVERABLE EMAIL 6/26/2019

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7300

222 Delaware Avenue, Suite 900

Richard William Riley

Pashman Stein Walder Hayden P.C.

Tel: +1 (302) 592-6496
Fax: +1 (732) 852-2482

824 North Market Street, Suite 800

Glenmark Generics Inc. USA Operating Company

Represented By

4 Attorneys Listed

Shashank S. Upadhye

Email: shashank@ipfdalaw.com

Richard William Riley

Pashman Stein Walder Hayden P.C.

Tel: +1 (302) 592-6496
Fax: +1 (732) 852-2482

824 North Market Street, Suite 800

Patrick C. Gallagher

Email: pcgallagher@duanemorris.com

Kevin M. Nelson

Email: kevin.nelson@afslaw.com

Plaintiff

SmithKline Beecham (Cork) Limited NPE (University / Research)

Represented By

4 Attorneys Listed

Delaney Laurel Doran

1261 W. Bridge St

Tel: +1 (215) 688-0425

1261 W. Bridge St, Spring City, PA 19422

Jeremy Douglas Anderson

Baker & Hostetler LLP

Tel: +1 (302) 319-2799

1201 N. Market Street, Ste #1407

Elizabeth M. Flanagan

Cooley LLP

Tel: +1 (312) 881-6383
Fax: +1 (312) 881-6598

30 S. 9th Street, 7th Floor

Douglas Edward McCann

Fish & Richardson, P.C.

Tel: +1 (302) 652-5070
Fax: +1 (302) 652-0607

222 Delaware Avenue, 17th Floor, P.O. Box 1114

GlaxoSmithKline LLC NPE (University / Research)

Represented By

10 Attorneys Listed

Delaney Laurel Doran

1261 W. Bridge St

Tel: +1 (215) 688-0425

1261 W. Bridge St, Spring City, PA 19422

William R. Woodford

UNDELIVERABLE EMAIL 5/6/2022

Robert M. Yeh

Email: ryeh@fr.com

Phillip W. Goter

Email: goter@fr.com

Michael A. Amon

Email: amon@fr.com

Limin Zheng

Email: lzheng@micleangleason.com

Jeremy Douglas Anderson

Baker & Hostetler LLP

Tel: +1 (302) 319-2799

1201 N. Market Street, Ste #1407

Elizabeth M. Flanagan

Cooley LLP

Tel: +1 (312) 881-6383
Fax: +1 (312) 881-6598

30 S. 9th Street, 7th Floor

Douglas Edward McCann

Fish & Richardson, P.C.

Tel: +1 (302) 652-5070
Fax: +1 (302) 652-0607

222 Delaware Avenue, 17th Floor, P.O. Box 1114

Craig E. Countryman

Email: countryman@fr.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
USRE40000
Method of treatment for decreasing mortality resulting from congestive heart failure
Filed: 2003-11-25
Issued: 2008-01-08
Expired (Term Ended)
Expires: 2023-11-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

28

Dispositive

15

Granted

1

Denied

0

Pending / Review

27

Motions by Category

Procedural / Extension Motion 4 Motion to Dismiss (FRCP 12(b)(6)) 12 Motion to Dismiss 3 Claim Construction / Markman Filing 9

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
MEMORANDUM ORDER re (38 in 1:14-cv-00877-LPS-CJB, 39 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATION -- Objections are OVERRULED and the Report is ADOPTED r...
Entry #54 • 2015-08-10 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
STATEMENT re (38 in 1:14-cv-00877-LPS-CJB, 39 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATIONS re (18 in 1:14-cv-00877-LPS-CJB) MOTION to Dismiss for Failur...
Entry #48 • 2015-05-29 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
STATEMENT re (38 in 1:14-cv-00877-LPS-CJB, 39 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATIONS re (18 in 1:14-cv-00877-LPS-CJB) MOTION to Dismiss for Failur...
Entry #43 • 2015-05-12 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPORT AND RECOMMENDATIONS recommending Granting in part D.I.(18 in 1:14-cv-00877-LPS-CJB) MOTION to Dismiss for Failure to State a Claim filed by Glenmark Gene...
Entry #38 • 2015-04-22 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REQUEST for Oral Argument by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited re 18 MOTION to Dismiss for Failure to State a Claim . (Hufnal, AnnaMartina)...
Entry #24 • 2014-11-26 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REQUEST for Oral Argument by Glenmark Generics Inc. USA re 18 MOTION to Dismiss for Failure to State a Claim . (Higgins, James) (Entered: 11/24/2014)
Entry #23 • 2014-11-24 Document →

Docket Entries

(80 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Glenmark Generics Inc. USA - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1547654.) - filed by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 07/07/2014)

Entry #1 • 2014-07-03
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 07/07/2014)

Entry #2 • 2014-07-03
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE40,000 E;. (dmp, ) (Main Document 3 replaced on 7/7/2014) (dmp, ). (Entered: 07/07/2014)

Entry #3 • 2014-07-03
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GlaxoSmithKline plc. for GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited filed by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. (dmp, ) (Entered: 07/07/2014)

Entry #4 • 2014-07-03
1
Pleading / Complaint

Return of Service Executed by GlaxoSmithKline LLC, SmithKline Beecham (Cork) Limited. Glenmark Generics Inc. USA served on 7/7/2014, answer due 7/28/2014. (Shear, William) (Entered: 07/08/2014)

Entry #5 • 2014-07-08
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc